Related Experiment Video
Updated: May 21, 2026
09:42
Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
Published on: September 7, 2017
TGF-β drives DNA demethylation.
1Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA 22908, USA. dw2p@virginia.edu
Molecular Cell
|June 12, 2012
Summary
Smad proteins drive specific DNA demethylation during transforming growth factor beta (TGF-β) signaling. This epigenetic modification is crucial for TGF-β
Area of Science:
- Molecular biology
- Epigenetics
- Cell signaling
Background:
- Transforming growth factor beta (TGF-β) signaling is a critical pathway regulating cell growth, differentiation, and development.
- DNA methylation is a key epigenetic mechanism influencing gene expression.
- The precise mechanisms by which TGF-β signaling regulates epigenetic modifications remain under investigation.
Discussion:
- This study investigates the role of Smad proteins, key mediators of TGF-β signaling, in epigenetic regulation.
- The findings highlight a direct link between Smad proteins and the active removal of DNA methylation.
- Locus-specific demethylation suggests a targeted epigenetic reprogramming controlled by TGF-β.
Key Insights:
- Smad proteins actively promote locus-specific DNA demethylation.
- This demethylation is an integral part of the transforming growth factor beta (TGF-β) transcriptional response.
- Provides a mechanistic link between TGF-β signaling and epigenetic control of gene expression.
Outlook:
- Further research can explore the downstream targets of this Smad-mediated demethylation.
- Understanding this process could reveal new therapeutic targets for diseases involving TGF-β dysregulation.
- Investigating the interplay between Smad proteins and other epigenetic modifiers.
More Related Videos
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
07:50Immunohistochemical Detection of 5-Methylcytosine and 5-Hydroxymethylcytosine in Developing and Postmitotic Mouse Retina
Published on: August 29, 2018
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:37Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
01:30General Transcription Factors
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
02:25Spreading of Chromatin Modifications
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...
Writers
The writer is an enzyme that can...